Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Blood Cancer
Leukemia & Lymphoma Society
Type of Organization: Foundation
Email Address: researchprograms@lls.org
Funds Available for Clinical Trials: ✗ Research: ✔
Other info: Program Name: Specialized Center of Research Program (SCOR)
A major emphasis in the SCOR grant program is on clinical translation of scientific results. Ideally, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation. There should be clear and direct “bench to bedside” translational trajectory from one or more of the Projects in the SCOR. It is important to note that the inclusion of a clinical trial in and of itself may not satisfy this requirement. Any clinical translation must be a coherent and integrated extension of other SCOR activities, and there should be substantive interactions and synergy between clinical trials and more basic or early translational Projects in the SCOR.
Applications for 2024-2025 program opens in Fall.
Leukemia & Lymphoma Society
Type of Organization: Foundation
Email Address: researchprograms@lls.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements:Other info: Program Name: Specialized Center of Research Program (SCOR)
A major emphasis in the SCOR grant program is on clinical translation of scientific results. Ideally, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation. There should be clear and direct “bench to bedside” translational trajectory from one or more of the Projects in the SCOR. It is important to note that the inclusion of a clinical trial in and of itself may not satisfy this requirement. Any clinical translation must be a coherent and integrated extension of other SCOR activities, and there should be substantive interactions and synergy between clinical trials and more basic or early translational Projects in the SCOR.
Applications for 2024-2025 program opens in Fall.